Xilio Therapeutics, Inc.

Ownership Transactions Reported by 37 Insiders

Symbol
XLO on Nasdaq
Industry
Pharmaceutical Preparations
Location
828 Winter Street, Waltham, MA

Insiders trading volume in the past year

Xilio Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gilead Sciences, Inc. 10%+ Owner $19.8M +$11.5M +137% Dec 18, 2024
Yekaterina Chudnovsky 10%+ Owner $5.32M Jun 7, 2024
SV7 Impact Medicine Fund LP 10%+ Owner $2.68M Oct 26, 2021
Bain Capital Life Sciences Investors, LLC 10%+ Owner $2.33M Dec 8, 2021
James E. Flynn Possible Member of 10% Group, 10%+ Owner $1.9M Oct 26, 2021
Atlas Venture Fund XI, L.P. 10%+ Owner $1.76M -$640 -0.04% Feb 8, 2024
Fmr Llc Other* $1.58M Oct 26, 2021
Takeda Pharmaceutical Co Ltd 10%+ Owner $1.22M Oct 26, 2021
RiverVest Venture Fund IV, L.P. 10%+ Owner $1.2M Oct 26, 2021
Rock Springs Capital Management LP 10%+ Owner $1.04M Oct 26, 2021
Bay City Capital Llc 10%+ Owner $937K Oct 26, 2021
Merck KGaA 10%+ Owner $565K Oct 26, 2021
Rene Russo PRESIDENT AND CEO, Director $393K Jan 1, 2025
FIL Ltd Other* $182K Oct 26, 2021
Alexandria Venture Investments, LLC 10%+ Owner $138K Oct 26, 2021
Simon Tomlinson 10%+ Owner $109K Oct 21, 2021
John Williams 10%+ Owner $83.1K Oct 21, 2021
of Ulrich Rodeck Estate 10%+ Owner $83.1K Oct 21, 2021
Timothy P. Clackson 10%+ Owner $75.5K Oct 21, 2021
Christopher James Frankenfield Chief Financial Officer $69.4K -$6.84K -8.97% Jan 1, 2025
Katarina Luptakova Chief Medical Officer $65.4K Jan 1, 2025
Kevin Brennan Svp, Finance And Accounting $18.7K -$1.77K -8.65% Jan 1, 2025
Rachel Humphrey Director $7.84K Oct 21, 2021
Sara Bonstein Director Jun 14, 2024
Aoife Brennan Director Jun 13, 2024
James Samuel Shannon Director Jun 13, 2024
Paul J. Clancy Director Jun 14, 2024
Martin H. Huber Jr. President And Head Of R&D Aug 16, 2023
Yuan Xu Director Jun 14, 2024
Tomas J. Heyman Director Jun 12, 2023
Robert W. Ross Director Jun 14, 2024
Daniel Lynch Director, 10%+ Owner Oct 21, 2021
Michael Jay Ross Director Jun 15, 2022
Edward C. English Principal Accounting Officer Jan 1, 2023
Salvatore Giovine Chief Financial Officer Feb 22, 2022
Christina Rossi Director Jun 14, 2024
Daniel J. Curran Director Jun 14, 2024

Recent Insider Transactions by Companies or Individuals for Xilio Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.